Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Radiation Therapy
100%
Prostate Cancer
76%
Oncology
45%
Clinical Trial
18%
Overall Survival
18%
External Beam Radiotherapy
17%
Prostate Specific Antigen
16%
Intensity Modulated Radiation Therapy
16%
Radiation Oncology
14%
Quality of Life
14%
Brachytherapy
13%
Androgen Deprivation Therapy
13%
Malignant Neoplasm
12%
Conformal Radiotherapy
12%
Prostatectomy
12%
Diseases
11%
Biochemical Recurrence
10%
Bladder
10%
Hazard Ratio
10%
Neoplasm
9%
Pelvis
8%
Treatment Planning
8%
Arm
8%
Bladder Cancer
7%
Distant Metastasis
7%
Recurrent Disease
7%
Proton Therapy
6%
Rhabdomyosarcoma
6%
Drug Megadose
6%
Computer Assisted Tomography
6%
Patient-Reported Outcome
6%
Carcinoma
6%
Stereotactic Body Radiation Therapy
5%
Adverse Event
5%
Gleason Score
5%
Tumor
5%
Urinary System
5%
Disease Free Survival
5%
Keyphrases
Radiation Therapy
43%
Prostate Cancer
33%
Radiation Therapy Oncology Group
22%
Radiotherapy
19%
Overall Survival
17%
Prostate-specific Antigen
16%
External Beam Radiotherapy
16%
Radiation Oncology
15%
Androgen Deprivation Therapy
15%
Prostate
14%
NRG Oncology
14%
Intensity-modulated Radiation Therapy
11%
Three-dimensional Conformal Radiotherapy
11%
Localized Prostate Cancer
10%
Quality of Life
10%
Hazard Ratio
9%
Confidence Interval
8%
Prostate Carcinoma
8%
Clinical Trials
8%
Radiation Therapy for Prostate Cancer
8%
Distant Metastasis
8%
Oncology
7%
Brachytherapy
7%
Intermediate-risk Prostate Cancer
7%
Biochemical Failure
7%
Multi-institutional
7%
Prostate Radiotherapy
7%
High-grade Prostate Cancer
7%
Salvage Radiotherapy
7%
Tumor
7%
Phase II Trial
6%
Quality Assurance
6%
American Society
6%
Prostate Cancer Patients
6%
Radical Prostatectomy
6%
Rhabdomyosarcoma
6%
Bladder Cancer
6%
Prostate-specific Antigen Level
6%
Bowel
6%
Chemotherapy
5%
Treatment Planning
5%
Patient-reported Outcomes
5%
Radiation Dose
5%
High Dose
5%
Dose Escalation
5%
Randomized Clinical Trial
5%